Alemtuzumab Alert: Understanding the Rare but Serious Kidney Risks
While alemtuzumab is effective for relapsing-remitting multiple sclerosis, a recent case underscores the importance of monitoring for rare but severe kidney complications like thrombotic microangiopathy (TMA). Learn about the signs, risks, and what to watch for.